arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Elanco Animal Health Inc

ELAN
$23.67 ▼ -1.62 (-6.41%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
39 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
36
Health
Weak
Bearish
auto_awesome

Analytical Summary

Elanco Animal Health Inc faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $11.8B
Dividend Yield —
Revenue Growth 10.2% ↘
Op. Margin —
ROIC —
FCF / Share $0.49 ↗
Trailing P/E 215.2x
Price / Book 1.8x
FCF Yield 2.1%
Debt / Equity 0.56
info Valuation on last close. End-of-day price, Nov 5, 2026.

39-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.37B
↑ +10.2% —
Net Income Profit after all expenses
$57.00M
↓ -14.9% —
FCF / Share Free cash flow per share
$0.49
↑ +739.8% —
Long-Term Debt Long-term obligations
$3.66B
↓ -2.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability →
34
Returns ↑
40
Financial Health ↓
46
Cash Quality ↓
9

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 11 years · 39 quarters